Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA1/TA2
This program seeks to develop a fieldable, scalable blood analog system for far-forward trauma care, removing dependence on cold chain and donor logistics. It aims to integrate sequentially administered blood analog components with ruggedized delivery, diagnostics, and clinical guidelines. The effort will advance components to Technology Readiness Level 7 and devices to TRL 8 through regulatory and commercialization strategies. Proposals are requested for Phase 1 of Task Area 1 and/or Task Area 2 only. No specific budget, performance location, or non-bid timelines are mentioned in the description.